Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fusidic acid betamethasone cream in infected atopic dermatitis/eczema (China)
CTR20180069Phase 3Suspended
- Sponsor
- LEO Pharma
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of betamethasone + fusidic acid in atopic dermatitis (AD), skin and soft tissue infections (SSTIs), sponsored by LEO Pharma. Started Jul 2018; status: suspended.
02
Drugs
betamethasone + fusidic acid
03
Conditions
atopic dermatitis (AD)skin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on CTR20180069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180069.